| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |